This inventor holds 6 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignee: Merrimack Pharmaceuticals, Inc.. Active years: 2014-2018.
Company Filing History:
Years Active: 2014-2018
Title: Raghida Bukhalid: Innovator in Antibody Therapeutics
Introduction
Raghida Bukhalid is a prominent inventor based in Melrose, MA (US), known for her significant contributions to the field of antibody therapeutics. With a total of six patents to her name, she has made remarkable strides in developing treatments for various disorders, particularly those related to the epidermal growth factor receptor (EGFR).
Latest Patents
Among her latest patents, Raghida has focused on antibodies against the epidermal growth factor receptor (EGFR) and their uses. These patents disclose anti-EGFR antibodies, therapeutic compositions that comprise combinations of these antibodies, and methods for utilizing such antibodies and compositions to treat EGFR-related disorders, including cancers. Her innovative work in this area has the potential to impact cancer treatment significantly.
Career Highlights
Raghida Bukhalid is currently associated with Merrimack Pharmaceuticals, Inc., where she continues to advance her research and development efforts. Her expertise in antibody therapeutics has positioned her as a key figure in the pharmaceutical industry, contributing to the development of novel treatments.
Collaborations
Raghida has collaborated with notable professionals in her field, including Ulrik Bjerl Nielsen and Michael Feldhaus. These collaborations have further enhanced her research and the impact of her inventions.
Conclusion
Raghida Bukhalid's work in antibody therapeutics exemplifies innovation and dedication to improving healthcare outcomes. Her contributions to the field, particularly in developing treatments for EGFR-related disorders, highlight her role as a leading inventor in the pharmaceutical industry.